Literature DB >> 11282774

Association of a promoter polymorphism of the CD14 gene and atopy.

G H Koppelman1, N E Reijmerink, O Colin Stine, T D Howard, P A Whittaker, D A Meyers, D S Postma, E R Bleecker.   

Abstract

Atopy is generally considered to be caused by interaction of genetic and environmental factors. Recently, an association of a C-to-T transition in the promoter region of the CD14 gene on chromosome 5q31.1 and atopic phenotypes was reported in a population study of school children in the United States. The aim of the present study was to investigate the association of the C allele of the CD14/-159 with phenotypes of atopy and asthma in an adult Dutch population in which linkage of total serum IgE and bronchial hyperresponsiveness to chromosome 5q31-33 is present. We studied 159 probands with asthma and 158 spouses as controls. Phenotypes for asthma (e.g., bronchial hyperresponsiveness, physician's diagnosis) and for atopy (e.g., total serum IgE level, intracutaneous skin test, allergic rhinitis) were studied. In this population, homozygotes for the C allele had a higher number of positive skin tests and higher total serum IgE levels (in skin test-positive individuals) and subsequently, more self-reported allergic symptoms including rhinitis and hay fever, compared with subjects with CT and TT alleles. We conclude that the -159 C-to-T promoter polymorphism in the CD14 gene may result in expression of a more severe allergic phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282774     DOI: 10.1164/ajrccm.163.4.2004164

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  49 in total

1.  Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations.

Authors:  Mamta Sharma; Jyotsna Batra; U Mabalirajan; Sangeeta Goswami; Dipyaman Ganguly; Brajen Lahkar; N K Bhatia; Amrendra Kumar; Balaram Ghosh
Journal:  Immunogenetics       Date:  2004-09-18       Impact factor: 2.846

2.  No Association Between -159C/T Polymorphism of the CD14 Gene and Asthma Risk: a Meta-Analysis of 36 Case-Control Studies.

Authors:  Rui Zhang; Rui Deng; He Li; Hong Chen
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 3.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

Review 4.  Gene-environment interactions in asthma: with apologies to William of Ockham.

Authors:  Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 5.  African Americans with asthma: genetic insights.

Authors:  Kathleen C Barnes; Audrey V Grant; Nadia N Hansel; Peisong Gao; Georgia M Dunston
Journal:  Proc Am Thorac Soc       Date:  2007-01

6.  Association of CD14 gene -159C/T polymorphism with allergic rhinitis risk: a meta-analysis.

Authors:  Yu Xu; Jun Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-30       Impact factor: 2.503

7.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

Review 8.  Soluble CD14: role in atopic disease and recurrent infections, including otitis media.

Authors:  Karin C Lødrup Carlsen; Berit Granum
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

9.  Temporal and spatial patterns of ambient endotoxin concentrations in Fresno, California.

Authors:  Ira B Tager; Frederick W Lurmann; Thaddeus Haight; Siana Alcorn; Bryan Penfold; S Katharine Hammond
Journal:  Environ Health Perspect       Date:  2010-05-21       Impact factor: 9.031

10.  Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis.

Authors:  Takeshi Hattori; Satoshi Konno; Ayumu Takahashi; Akira Isada; Kaoruko Shimizu; Kenichi Shimizu; Natsuko Taniguchi; Peisong Gao; Etsuro Yamaguchi; Nobuyuki Hizawa; Shau-Ku Huang; Masaharu Nishimura
Journal:  BMC Med Genet       Date:  2010-10-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.